Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
주식 순위 #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
주가
$0.52468396
시가총액
$37.85M
변동 (1일)
1.23%
변동 (1년)
-4.53%
국가
TW
거래 Enimmune corporation (6564)

카테고리

Enimmune corporation (6564)의 주가 이력
최고 종가: $0.53 (2026-08-01 기준)

최저 종가: $0.89 (2018-09-01 기준)
Enimmune corporation의 주가 이력 (2018 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$543.36 37.78%
US
$1.03K 55.65%
NL
$120.74 -14.98%
AU
$139.64 419.30%
US
$762.65 7.15%
CH